# Validated RP‐HPLC‐UV Method for Simultaneous Quantification of Aminophenazone, Dipyrine, and Chlorpheniramine Maleate in Pharmaceutical Formulations Considering Dipyrine Decomposition

**Authors:** Md. Abid Hasan, Sajia Azmi, Tasnuma Tabassum, Ejaj Sumit, Abdul Gafur, Naima Helal

PMC · DOI: 10.1155/ianc/7435313 · 2026-01-31

## TL;DR

This paper presents a validated HPLC method for measuring three drugs in pharmaceuticals, accounting for dipyrine decomposition.

## Contribution

A new RP-HPLC-UV method is developed and validated for simultaneous quantification of aminophenazone, dipyrine, and chlorpheniramine maleate.

## Key findings

- The method successfully elutes all three compounds with no interference.
- The calibration curves were linear across specified concentration ranges.
- The method showed good precision and accuracy with recovery within 98.0–102.0%.

## Abstract

Aminophenazone, dipyrine, and chlorpheniramine maleate combined drug is used as antipyrine and analgesic. In this study, a rapid, robust, and straightforward high‐performance liquid chromatographic (HPLC) technique was developed, optimized, and validated for simultaneous analysis of aminophenazone, dipyrine, and chlorpheniramine maleate taking into account decomposition of dipyrine. On a C18 (4.6 mm × 15 cm; 5 μm) Shim‐pack column, aminophenazone, dipyrine, and chlorpheniramine maleate were successfully eluted by using mobile phase, comprising water: methanol: triethylamine: glacial acetic acid (70:28:1:1 v/v/v/v) at flow rate 1.0 mL/min and wavelength of 254 nm. About 5 mg/mL sodium sulfite in diluent and mobile phase was used to prevent the hydrolysis of dipyrine after several investigations. The validation parameters, including specificity, linearity, LOD/LOQ, precision, accuracy, robustness, and solution stability, were verified for performance of the method. In specificity study, there was not any interference with main peak. The constructed calibration curve was found to be linear in the concentration ranges of 0.1–1.0 (aminophenazone), 0.1–1.0 (dipyrine), 0.002–0.020 (chlorpheniramine maleate) mg/mL, respectively. The % recovery at different concentrations was within the (98.0–102.0) %. When the column temperature, the flow rate, wavelength, and mobile phase composition were changed, the absolute difference of the content at different modified conditions were within 2.0 (%RSD) of the original condition. The solution was stable upto 24 h in room temperature (benchtop), autosampler (15°C–25°C), and refrigerator (2–8 degree). This method was successfully employed for the analysis of aminopyrine, metamizole, and chlorpheniramine maleate in marketed products, and the results were satisfactory. The confirmed RP‐HPLC‐UV method may be a workable analytical approach on a routine analysis.

## Linked entities

- **Chemicals:** aminophenazone (PubChem CID 6009), dipyrine (PubChem CID 6009), chlorpheniramine maleate (PubChem CID 5281068), sodium sulfite (PubChem CID 24437), triethylamine (PubChem CID 8471), glacial acetic acid (PubChem CID 176), metamizole (PubChem CID 3111)

## Full-text entities

- **Chemicals:** glacial acetic acid (MESH:D019342), antipyrine (MESH:D000983), water (MESH:D014867), methanol (MESH:D000432), triethylamine (MESH:C016162), Chlorpheniramine Maleate (MESH:D002744), metamizole (MESH:D004177), Aminophenazone (MESH:D000632), sodium sulfite (MESH:C025026)
- **Mutations:** C-25 C

## Figures

16 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12860220/full.md

---
Source: https://tomesphere.com/paper/PMC12860220